Published on:

Merck to pay $80 million to settle Vioxx litigation

Merck & Co. anticipates paying $80 million to settle litigation in regards to its former pain drug Vioxx. The U.S. Security and Exchange Commission has terminated its Vioxx investigation, which Merck withdrew from the market in 2004.

To read more about the Merck settlement.